Tumor level
Distance from anal verge, relationship to sphincter, mesorectal fascia and pelvic structures are documented.
A focused review for rectal cancer cases, emphasizing pelvic MRI, distance from the anal verge, sphincter involvement, neoadjuvant treatment history, metastatic status and functional outcomes.
Rectal cancer review is not the same as colon cancer review because pelvic anatomy, sphincter preservation, radiation history and local recurrence risk are central. The file should show the exact tumor level and local extension.
International coordination should clarify whether the question is local control, organ preservation, metastatic management, post-surgery recurrence or supportive care planning.
Distance from anal verge, relationship to sphincter, mesorectal fascia and pelvic structures are documented.
T stage, nodal status, EMVI, CRM/mesorectal fascia and response after neoadjuvant therapy are reviewed.
Chemoradiation, total neoadjuvant therapy, surgery, chemotherapy and response are summarized.
Colostomy/ileostomy status, bowel function, pain and pelvic symptoms are included.
Liver, lung, peritoneal or nodal metastases are documented with recent imaging.
The file defines whether the patient needs second opinion, post-progression review or functional planning.
Each item below affects how the file is interpreted, what the physician can answer and whether additional documents are needed before a responsible response.
MRI pelvis report is often central for local staging and response assessment.
Prior pelvic radiation affects future local treatment discussions.
Functional goals must be realistic and physician-led.
Metastatic disease is reviewed alongside local pelvic symptoms and previous regimens.
Most delays happen when the diagnosis is described verbally but the file lacks dates, reports, imaging, pathology or the current specialist recommendation. The documents below are requested before the file is considered ready for review.
The page does not present a hospital visit or travel plan as automatically suitable. Any Cuba-related discussion remains conditional on physician review of the current file.
The physician must know whether the main problem is pelvic disease, metastases or both.
Stoma, pain, bowel control and nutrition affect coordination.
A clear route requires current imaging and treatment history.
No Cuba-related option takes precedence over proven standard treatment.
In rectal cancer the decisive element is local stage on pelvic MRI and the relationship to surrounding structures. In locally advanced disease, preoperative chemoradiotherapy or total neoadjuvant therapy are standard, and this sequence directly affects the chance of sphincter-preserving surgery. The plan must therefore be settled before any operation.
Cuba-related products have been studied in specific tumour types and are licensed in Cuba within their own approved indications. In this diagnosis the real contribution of an international review is to re-examine the current plan, check whether an option has been missed, and identify what is missing from the file. That is only possible with a complete and current record.
The file should therefore contain the full pathology report, staging imaging, a list of treatments given with dates and doses, current blood tests and the most recent oncology consultation note. An incomplete file causes both misdirection and avoidable delay.
The pelvic MRI report, relationship to the mesorectal fascia and distance from the anal verge determine the surgical decision.
RAS, BRAF and MSI/dMMR status affect treatment selection in advanced disease.
Radiotherapy field and dose, chemotherapy given and any stoma should be documented.
International coordination should never delay emergency care. If any of the following are present, the patient should be assessed locally first.
No. It explains how the file is organized for review. Suitability, route, timing and safety can only be determined by physicians after reviewing the complete current record.
A summary helps, but it is not enough for most oncology reviews. Pathology, imaging, treatment history, lab results and the latest oncology note are usually needed.
No. Cuba Health Assist coordinates records, communication, translation support and logistics. Medical decisions remain with licensed physicians and the patient’s treating team.
The team will request missing reports before presenting the case as ready. This protects the patient from receiving a weak or unrealistic response.
No. Severe or rapidly worsening symptoms require local emergency or oncology care first. International coordination is not an emergency service.
A coordinator will organize the medical information and guide the next step according to specialist review. The process is designed to be transparent, clinically cautious and written.